Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Rheumatology (Oxford) ; 46(4): 590-6, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17043042

RESUMEN

OBJECTIVES: The pathogenesis of reactive arthritis (ReA), an aseptic synovitis that follows an extra-articular infection, is incompletely known. We studied the impact of tumour necrosis factor receptor (TNFR) p55 deficiency on the progression to ReA after oral Yersinia enterocolitica O:3 infection, the Yersinia antigens triggering articular inflammation and a possible articular TNFRp55-mediated mechanism that protects against ReA. METHODS: Wild-type C57BL/6 and TNFRp55-/- mice were orogastrically infected with Y. enterocolitica O:3 and monitored for survival and arthritis development. The bacterial load was determined in mesenteric lymph nodes (MLNs), the spleen and joints. Interferon (IFN)-gamma, TNF-alpha and IL-10 mRNA expression in MLN and joints were analysed by reverse transcription-polymerase chain reaction (RT-PCR). Articular antibodies to Yersinia antigens, TNF-alpha protein and nitric oxide (NO) levels were assessed. Acute arthritis was evaluated after joint injection of Yersinia antigens. RESULTS: The survival rate was 60% in TNFRp55-/- mice. They showed impaired bacterial clearance in MLN, the spleen and joints, and excessive mRNA expression of pro-inflammatory cytokines in MLN. Clinical and histological examinations revealed that TNFRp55-/- mice developed severe arthritis. Moreover, augmented articular outer membrane protein (OMP)-specific antibodies and TNF-alpha but impaired NO levels were detected in TNFRp55-/- mice. Synovial inflammatory response was detected by joint OMP injection. CONCLUSIONS: TNFRp55-mediated immune mechanisms prevent ReA development after oral infection with Y. enterocolitica O:3. Yersinia OMPs are the relevant antigens triggering ReA. NO induction through TNFRp55 signalling could have a local antibacterial function to prevent ReA. This study could contribute to ReA-specific therapeutic studies.


Asunto(s)
Antígenos Bacterianos/inmunología , Artritis Experimental/inmunología , Artritis Reactiva/inmunología , Receptores Tipo I de Factores de Necrosis Tumoral/inmunología , Yersiniosis/inmunología , Yersinia enterocolitica/inmunología , Animales , Anticuerpos Antibacterianos/biosíntesis , Artritis Experimental/microbiología , Artritis Experimental/patología , Artritis Reactiva/microbiología , Artritis Reactiva/patología , Susceptibilidad a Enfermedades , Articulaciones/inmunología , Ratones , Ratones Endogámicos C57BL , Óxido Nítrico/biosíntesis , Receptores Tipo I de Factores de Necrosis Tumoral/deficiencia , Factor de Necrosis Tumoral alfa/biosíntesis , Yersiniosis/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA